全球體外受精 (IVF) 顯微鏡市場:市場規模、佔有率、成長分析、依產品類型、最終用戶分類 - 產業預測,2023-2030 年
市場調查報告書
商品編碼
1396182

全球體外受精 (IVF) 顯微鏡市場:市場規模、佔有率、成長分析、依產品類型、最終用戶分類 - 產業預測,2023-2030 年

Global In-vitro Fertilization Microscopes Market Size, Share, Growth Analysis, By Product Type(Inverted microscopes, stereo microscopes), By End-user(Fertility clinics, hospitals) - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2021年,全球體外受精(IVF)顯微鏡市場規模為1億405萬美元,從2022年的1.1611億美元成長到2030年的1億1611萬美元,預測期間(2023-2030年)複合年成長率為7.43%。

全球體外受精 (IVF) 顯微鏡市場目前正在快速成長,預計在可預見的未來將保持這種上升趨勢。促成這一市場擴張的主要因素包括全球不孕症發病率的增加、顯微鏡技術的不斷進步以及人們對不孕症治療成功率的認知不斷提高。不孕率上升是由於生活方式的改變、環境影響以及推遲懷孕的趨勢,促使對輔助生殖技術的需求增加,特別是體外受精(IVF),而IVF)正在推動顯微鏡市場的發展。此外,顯微鏡技術的不斷進步徹底改變了輔助生殖技術領域。高解析度成像功能和創新功能的提供徹底改變了胚胎可視化和操作。因此,生育專家能夠提高體外受精的成功率。人們對不孕症治療有效性的認知不斷提高,進一步推動了市場的成長,越來越多的患者和醫療保健提供者選擇體外受精 (IVF) 顯微鏡。此外,政府的支持措施和醫療基礎設施的發展也在市場擴張中發揮重要作用。新興市場的一個趨勢是開發專專用體外受精 (IVF) 設計的攜帶式手持式顯微鏡。這些緊湊的攜帶式設備提供了極大的彈性和便利性,有助於現場不孕症測試和診斷。攜帶式顯微鏡使生育專家能夠進行現場評估,減少樣本運輸的需要,並在體外受精 (IVF) 過程中實現即時決策,這將成為可能。這一趨勢在資源有限的環境中尤其有利,並將大大有助於提高不孕症治療的可近性。

體外受精 (IVF) 顯微鏡全球市場區隔分析

全球體外受精 (IVF) 顯微鏡市場可根據產品類型、最終用戶和地區進行區隔。依產品類型分為倒置顯微鏡、體視顯微鏡、螢光顯微鏡和共聚焦顯微鏡。依最終用戶分類,市場分為生育診所、醫院和研究機構。依地區分類,分為北美、歐洲、亞太地區、中東/非洲、拉丁美洲。

體外受精 (IVF) 顯微鏡的全球市場促進因素

全球不孕症現像日益增加:由於生活方式改變、環境影響、延遲懷孕等導致不孕症患者數量迅速增加,是推動輔助生殖技術尤其是體外受精需求的主要因素。隨著越來越多的個人和夫婦在自然受孕方面面臨課題,對先進輔助生殖技術(包括使用體外受精 (IVF) 顯微鏡)的需求顯著增加。這種不斷成長的需求正在為製造商和行業供應商創造有利的市場形勢。

全球體外受精(IVF)顯微鏡市場的抑制因素

IVF治療及相關技術高成本:IVF治療涉及多個週期、藥物治療、實驗室檢查以及精密顯微鏡設備的使用,對患者來說不經濟,是一個很大的負擔。體外受精治療的高成本可能會限制其可用性和普及,從而阻礙其廣泛使用。此外,體外受精 (IVF) 顯微鏡及其維護的高成本可能會影響其普及,特別是在資源有限的環境和經濟困難的患者中。

體外受精 (IVF) 顯微鏡的全球市場趨勢

強調延時成像技術:延時成像技術在體外受精 (IVF) 中越來越受到關注,在胚胎發育過程中定期連續拍攝影像。該技術提供了胚胎品質和動態的寶貴見解,並允許對型態變化和發育里程碑進行詳細評估。生育專家正在利用這一趨勢來非侵入性地監測胚胎髮育,並旨在透過選擇具有更高發育潛力的胚胎來提高體外受精的成功率。延時成像的採用反映了在體外受精 (IVF) 過程中改善胚胎選擇和移植決策的策略重點。

目錄

  • 執行摘要
  • 調查方法
  • 母市場分析
  • 主要市場考察
    • 技術分析
    • 價格分析
    • 供應鏈分析
    • 價值鏈分析
    • 市場生態系統
    • 智慧財產權分析
    • 貿易分析
    • Start-Ups分析
    • 原料分析
    • 創新矩陣
    • 研發線產品分析
    • 總體經濟指標
    • 主要投資分析
    • 關鍵成功因素
    • 競爭程度
  • 市場動態及展望
    • 市場動態
      • 促進因素
      • 機會
      • 抑制因素
      • 任務
    • 監管形勢
    • 波特的分析
    • 對未來中斷的特殊考察
  • 依產品類型分類的全球體外受精 (IVF) 顯微鏡市場
    • 市場概況
    • 倒置顯微鏡
    • 體視顯微鏡
    • 螢光顯微鏡
    • 共聚焦顯微鏡
  • 全球體外受精 (IVF) 顯微鏡市場:依最終用戶分類
    • 市場概況
    • 不孕不育診所
    • 醫院
    • 研究機構
  • 依地區分類的體外受精 (IVF) 顯微鏡的全球市場規模
    • 市場概況
    • 北美洲
      • 美國
      • 加拿大
    • 歐洲
      • 德國
      • 西班牙
      • 法國
      • 英國
      • 其他歐洲國家地區
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 其他亞太地區
    • 拉丁美洲
      • 巴西
      • 其他拉丁美洲地區
    • 中東和非洲 (MEA)
      • 海灣合作理事會國家
      • 南非
      • 其他中東/非洲地區
  • 競爭形勢
    • 前5名企業對比
    • 主要企業市場定位(2021年)
    • 主要市場參與者所採取的策略
    • 關鍵成功策略
    • 近期市集活動
    • 主要企業市場佔有率(2021年)
  • 主要企業簡介
    • Leica Microsystems GmbH(Germany)
    • Nikon Corporation(Japan)
    • Olympus Corporation(Japan)
    • Carl Zeiss AG(Germany)
    • Thermo Fisher Scientific Inc.(US)
    • CooperSurgical, Inc.(US)
    • Research Instruments Ltd.(UK)
    • Vitrolife AB(Sweden)
    • Eppendorf AG(Germany)
    • Hamilton Thorne, Inc.(Canada)
    • RI.MOS. srl(Italy)
    • Kitazato Corporation(Japan)
    • Esco Micro Pte. Ltd.(Singapore)
    • Labotect GmbH(Germany)
    • Microptic SL(Spain)
    • Cook Medical LLC(US)
    • Xilloc Medical BV(Netherlands)
    • K-Systems Corp.(US)
    • IVFtech ApS(Denmark)
    • Genea Biomedx(Australia)
簡介目錄
Product Code: SQMIG35A2620

Global In-Vitro Fertilization Microscopes Market size was valued at USD 104.05 million in 2021 and is poised to grow from USD 116.11 million in 2022 to USD 206.03 million by 2030, at a CAGR of 7.43% during the forecast period (2023-2030).

The global market for in-vitro fertilization microscopes is currently undergoing rapid growth and is anticipated to sustain this upward trajectory in the foreseeable future. This expansion is primarily driven by key factors, including the increasing prevalence of infertility worldwide, continuous advancements in microscopy technology, and a growing awareness of the favourable success rates associated with fertility treatments. The rise in infertility rates is attributable to lifestyle shifts, environmental influences, and the tendency to postpone pregnancies, consequently generating heightened demand for assisted reproductive technologies, specifically in-vitro fertilization, thereby propelling the market for IVF microscopes. Moreover, the ongoing evolution of microscopy technology has brought about a significant transformation in the field of assisted reproduction. The provision of high-resolution imaging capabilities and innovative features has revolutionized embryo visualization and manipulation. This, in turn, enables fertility specialists to achieve enhanced success rates in IVF procedures. The increasing awareness of the efficacy of fertility treatments has further catalysed market growth, with a growing number of patients and healthcare providers opting for IVF microscopes. Additionally, supportive government initiatives and improvements in healthcare infrastructure are playing a pivotal role in facilitating the expansion of the market. An emerging trend in the market is the development of portable and handheld microscopes specifically designed for in-vitro fertilization. These compact and mobile devices offer a high degree of flexibility and convenience, facilitating point-of-care fertility testing and diagnosis. The use of portable microscopes empowers fertility specialists to conduct on-site evaluations, thereby reducing the necessity for sample transportation and enabling real-time decision-making during the IVF process. This trend proves particularly advantageous in resource-limited settings and contributes significantly to enhancing accessibility to fertility treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global In-Vitro Fertilization Microscopes Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global In-Vitro Fertilization Microscopes Market Segmental Analysis

The global In-vitro Fertilization Microscopes market can be segmented based on product type, end-user and region. Based on product type, the market can be segmented into inverted microscopes, stereo microscopes, fluorescence microscopes, confocal microscopes. Based on end-use, the market can be segmented into Fertility clinics, hospitals, research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global In-Vitro Fertilization Microscopes Market

Increasing Global Incidence of Infertility: The surge in infertility cases, attributed to lifestyle shifts, environmental influences, and delayed pregnancies, is a primary driver propelling the demand for assisted reproductive technologies, notably in-vitro fertilization. As a growing number of individuals and couples encounter challenges in natural conception, the demand for advanced fertility treatments, including the utilization of IVF microscopes, experiences a significant upswing. This escalating demand creates a favourable market landscape for manufacturers and industry suppliers.

Restraints in the Global In-Vitro Fertilization Microscopes Market

High Cost of IVF Treatments and Associated Technologies: The expense associated with IVF procedures, encompassing multiple cycles, medications, laboratory tests, and the use of advanced microscopy equipment, presents a considerable financial burden for patients. The elevated cost of IVF treatments may limit accessibility and affordability, hindering widespread adoption. Furthermore, the high cost of IVF microscopes and their maintenance may impact adoption rates, especially in resource-limited settings and among patients with constrained financial resources.

Market Trends of the Global In-Vitro Fertilization Microscopes Market

Emphasis on Time-Lapse Imaging Technology: Time-lapse imaging technology is gaining prominence within in-vitro fertilization, involving the continuous capture of images at regular intervals during embryo development. This technique enables a detailed assessment of morphological changes and developmental milestones, offering valuable insights into embryo quality and kinetics. Fertility specialists leverage this trend for non-invasive monitoring of embryo development, aiming to enhance IVF success rates by selecting embryos with the highest developmental potential. The adoption of time-lapse imaging reflects a strategic focus on improving decision-making in embryo selection and transfer during IVF procedures.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
    • Regulatory Landscape
    • Porters Analysis
      • Competitive rivalry
      • Threat of Substitute Products
      • Bargaining Power of Buyers
      • Threat of New Entrants
      • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
      • Political Impact
      • Economic Impact
      • Social Impact
      • Technical Impact
      • Environmental Impact
      • Legal Impact
  • Global In-vitro Fertilization Microscopes Market by Product Type
    • Market Overview
    • Inverted microscopes
    • stereo microscopes
    • fluorescence microscopes
    • confocal microscopes
  • Global In-vitro Fertilization Microscopes Market by End-user
    • Market Overview
    • Fertility clinics
    • hospitals
    • research institutes
  • Global In-vitro Fertilization Microscopes Market Size by Region
    • Market Overview
    • North America
      • USA
      • Canada
    • Europe
      • Germany
      • Spain
      • France
      • UK
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC Countries
      • South Africa
      • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
      • By Development
      • By Company
      • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Leica Microsystems GmbH (Germany)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Nikon Corporation (Japan)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Olympus Corporation (Japan)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Carl Zeiss AG (Germany)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Thermo Fisher Scientific Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • CooperSurgical, Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Research Instruments Ltd. (UK)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Vitrolife AB (Sweden)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Eppendorf AG (Germany)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Hamilton Thorne, Inc. (Canada)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • RI.MOS. srl (Italy)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Kitazato Corporation (Japan)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Esco Micro Pte. Ltd. (Singapore)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Labotect GmbH (Germany)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Microptic SL (Spain)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Cook Medical LLC (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Xilloc Medical B.V. (Netherlands)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • K-Systems Corp. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • IVFtech ApS (Denmark)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Genea Biomedx (Australia)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments